Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Drug Metabolism and Drug Interactions
|
April 23, 2010
Molecular modelling of CYP2F substrates: comparison of naphthalene metabolism by human, rat and mouse CYP2F subfamily enzymes
David F V Lewis, Yuko Ito, Brian G Lake
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 27, 2010
Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences
David F V Lewis, Yuko Ito, Brian G Lake
Thescientificworldjournal
|
June 27, 2006
The astronomical pulse of global extinction events
David F V Lewis, Jean-Lou C M Dorne
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 22, 2007
Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity
David F V Lewis, Brian G Lake, Maurice Dickins
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
April 14, 2005
Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activity
David F V Lewis, Brian G Lake, Michael G Bird
Drug Metabolism and Drug Interactions
|
May 20, 2003
Molecular modelling of the mouse cytochrome P450 CYP2F2 based on the CYP102 crystal structure template and selective CYP2F2 substrate interactions
David F V Lewis, Paul T Bailey, Lawrence K Low
Journal of Molecular Graphics & Modelling
|
September 4, 2007
Analysis of CYP2D6 substrate interactions by computational methods
Yuko Ito, Hiroki Kondo, Peter S Goldfarb, et al.
Drug Metabolism and Drug Interactions
|
July 18, 2006
Quantitative structure-activity relationships (QSARs) within cytochromes P450 2B (CYP2B) subfamily enzymes: the importance of lipophilicity for binding and metabolism
David F V Lewis, Brian G Lake, Yuko Ito, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 25, 2006
Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes
David F V Lewis, Brian G Lake, Yuko Ito, et al.
Plos One
|
May 22, 2013
Modelling species selectivity in rat and human cytochrome P450 2D enzymes
Grace H C Edmund, David F V Lewis, Brendan J Howlin
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Drug Metabolism and Drug Interactions
|
April 23, 2010
Molecular modelling of CYP2F substrates: comparison of naphthalene metabolism by human, rat and mouse CYP2F subfamily enzymes
David F V Lewis, Yuko Ito, Brian G Lake
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 27, 2010
Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences
David F V Lewis, Yuko Ito, Brian G Lake
Thescientificworldjournal
|
June 27, 2006
The astronomical pulse of global extinction events
David F V Lewis, Jean-Lou C M Dorne
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 22, 2007
Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity
David F V Lewis, Brian G Lake, Maurice Dickins
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
April 14, 2005
Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activity
David F V Lewis, Brian G Lake, Michael G Bird
Drug Metabolism and Drug Interactions
|
May 20, 2003
Molecular modelling of the mouse cytochrome P450 CYP2F2 based on the CYP102 crystal structure template and selective CYP2F2 substrate interactions
David F V Lewis, Paul T Bailey, Lawrence K Low
Journal of Molecular Graphics & Modelling
|
September 4, 2007
Analysis of CYP2D6 substrate interactions by computational methods
Yuko Ito, Hiroki Kondo, Peter S Goldfarb, et al.
Drug Metabolism and Drug Interactions
|
July 18, 2006
Quantitative structure-activity relationships (QSARs) within cytochromes P450 2B (CYP2B) subfamily enzymes: the importance of lipophilicity for binding and metabolism
David F V Lewis, Brian G Lake, Yuko Ito, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 25, 2006
Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes
David F V Lewis, Brian G Lake, Yuko Ito, et al.
Plos One
|
May 22, 2013
Modelling species selectivity in rat and human cytochrome P450 2D enzymes
Grace H C Edmund, David F V Lewis, Brendan J Howlin
Page
of 6